Universal Navigation

Join or Renew Your Membership Join Now

S10 - Biomarkers in Movement Disorders

Event Time:	Sunday May 5, 2019 3:30 pm to 5:30 pm
Topic(s):	Movement Disorders
Director(s):
Description:
Completion Message:
CME Credits:	2
Core Competencies:

Program Speakers - Tentative
Start/End Time	Title	Faculty
5:10 PM - 5:30 PM	Q&A Panel with Authors	Faculty

Disclosures
Speaker	Disclosure

Abstract Presenters
Start Time	Pub.	Title	Presenter
3:30 PM	001	Identifying Biomarkers for Parkinson’s Disease with Reflex Tears	Disclosure: Dr. Lew has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Teva, USWM, Abbvie, Lundbeck, Acadia , UCB, Revance, Adamas, Sunovion, Neurocrine. Dr. Lew has received research support from Neuroderm, Pharm2b, Enterin Inc, Michael J. Fox Foundation, Cala Health, Biotie, Parkinson's Study Group.
3:30 PM	002	Repeat Submandibular Gland Biopsies as a Progression Marker in Parkinson’s Disease	Disclosure: Dr.Adler has received personal compensation for consulting serving on a scientific advisory board speaking or other activities with Acadia Jazz Neurocrine Scion and Sunovion.
3:30 PM	003	Deep Immunophenotyping Reveals ‘Older’ T cell And B cell Compartments in Patients with Parkinson’s Disease	Disclosure: Dr. Li has nothing to disclose.
3:30 PM	004	Cortical Phase Amplitude Coupling and Pathologic Synchronization during Sleep in Parkinson’s Disease	Disclosure: Dr. Higginbotham has nothing to disclose.
3:30 PM	005	Longitudinal Characterization of the Clinical and DAT Characteristics of Participants with Scans without Evidence of Dopaminergic Deficit (SWEDDs): PPMI Cohort	Disclosure: Dr. Marek has nothing to disclose.
3:30 PM	006	Capturing Parkinson’s disease heterogeneity with quantitative mobility measures	Disclosure: Dr. Hill has nothing to disclose.
3:30 PM	007	Nilotinib is a Multi Kinase Inhibitor that Alters Cerebrospinal Fluid (CSF) Biomarkers and Increases TREM2 Levels in Individuals with Parkinson Disease.	Disclosure: Dr. Moussa has nothing to disclose.
3:30 PM	008	Unbiased Phenotype-Based Chemical Modifier Screen In Vivo Reveals Novel Small Molecule Modulators Of Tauopathy	Disclosure: Dr. Bai has nothing to disclose.
3:30 PM	009	Cerebrospinal Fluid AD Biomarkers and Regional [18F]-Flortaucipir Uptake in Lewy Body Disorders	Disclosure: Dr. Coughlin has nothing to disclose.

Ready to register for the 2019 AAN Annual Meeting?

Related Courses

Saturday, May 4, 2019
7:00 AM-9:00 AM
C6 - Therapy of Movement Disorders: A Case-based Approach David Riley MD
9:30 AM-11:30 AM
C18 - Cerebellar and Afferent Ataxias: Diagnosis and Management Massimo Pandolfo MD, FAAN
1:30 PM-3:30 PM
C34 - Evaluating Tremor in the Office Andres Deik Acosta Madiedo MD
2:30 PM-3:15 PM
Dancing with Parkinson's Diviya Kaul MD
4:15 PM-5:30 PM
Hot Topics Plenary Session Eric Klawiter MD, FAAN

Sunday, May 5, 2019
7:00 AM-9:00 AM
C42 - The Dystonias: Diagnosis, Treatment and Update on Etiologies Rachel Saunders-Pullman MD
11:30 AM-6:30 PM
P1 - Poster Session 1
1:00 PM-3:00 PM
C51 - Balance and Gait Disorders Alfonso Fasano MD, PhD
S4 - Clinical Trials in Movement Disorders
3:30 PM-5:30 PM
C67 - Neurology Update II: Behavioral Neurology, Movement Disorders, and Neuro-ophthalmology Ralph Jozefowicz MD, FAAN, Adam Quick MD
C72 - Disordered Sleep in Common Neurologic Diseases: Traumatic Brain Injury, Stroke, and Parkinson’s Disease LynnMarie Trotti MD
N1 - Neuroscience in the Clinic: Child Neurology: Emerging Understanding of the Epilepsy-Movement Disorder Spectrum Across the Lifespan Deborah Hall MD, PhD, FAAN, Erika Augustine MD, FAAN

Monday, May 6, 2019
7:00 AM-9:00 AM
C83 - Diagnosis and Treatment of Functional Movement Disorders Mark Hallett MD, FAAN
C87 - Skills Workshop: Clinical Usefulness of Botulinum Toxin for Spasticity (Registration Required) Allison Brashear MD, MBA, FAAN
11:30 AM-6:30 PM
P2 - Poster Session 2
1:00 PM-3:00 PM
C93 - Paroxysmal Movement Disorders Kailash Bhatia MD, FAAN
S16 - Huntington's Disease: From Bench to Clinical Trials
1:00 PM-5:30 PM
C105 - Skills Workshop: Clinical Uses of Botulinum Toxin for Dystonia (Registration Required) Diego Torres-Russotto MD, FAAN
3:30 PM-5:30 PM
C117 - Tourette Syndrome: Assessment and Management Tamara Pringsheim MD, FAAN
5:00 PM-5:45 PM
Careers in Movement Disorders Stanley Fahn MD, FAAN

Tuesday, May 7, 2019
7:00 AM-9:00 AM
C127 - Hyperkinetic Movement Disorders: Videodiagnosis and Treatment Steven Frucht MD
11:30 AM-6:30 PM
P3 - Poster Session 3
1:00 PM-3:00 PM
C137 - Deep Brain Stimulation I: Basic Principles and Programming in Movement Disorders Michael Pourfar MD
3:30 PM-5:30 PM
C155 - Deep Brain Stimulation II: Advanced Management in Movement Disorders and Applications Beyond Movement Disorders Leonard Verhagen Metman MD, PhD
IS2 - Invited Science: Movement Disorders Deborah Hall MD, PhD, FAAN

Wednesday, May 8, 2019
7:00 AM-9:00 AM
C168 - Parkinson's Disease Update Melissa Nirenberg MD, PhD, FAAN
C170 - Video EEG: Name That Spell Amy Crepeau MD
8:00 AM-8:45 AM
Complementary Therapies in Parkinson's Disease Veronica Santini MD
11:30 AM-6:30 PM
P4 - Poster Session 4
1:00 PM-1:45 PM
Understanding the AAN's Latest Guidelines Tamara Pringsheim MD, FAAN
1:00 PM-3:00 PM
C179 - Nonmotor Manifestations of Parkinson's Disease I Jennifer Goldman MD, MS, FAAN
C185 - Actualización en trastornos del movimiento (Update in Movement Disorders) Andres Deik Acosta Madiedo MD
3:30 PM-5:30 PM
C196 - Nonmotor Manifestations of Parkinson's Disease II Jennifer Goldman MD, MS, FAAN
N5 - Neuroscience in the Clinic: Wearable Technology Deborah Hall MD, PhD, FAAN, Eric Klawiter MD, FAAN
S41 - Imaging in Movement Disorders

Thursday, May 9, 2019
7:00 AM-9:00 AM
C209 - Movement Disorders for the General Neurologist I: New Concepts in the Diagnosis and Management of Parkinson's Disease Irene Litvan MD, FAAN
11:30 AM-6:30 PM
P5 - Poster Session 5
1:00 PM-3:00 PM
C220 - Movement Disorders for the General Neurologist II: Tremor, Drug-induced Movement Disorders, RLS, and Ataxia Joohi Jimenez Shahed MD
3:30 PM-5:30 PM
C233 - Therapy in Neurology IV: Movement Disorders and Stroke David Dodick MD, FAAN
C234 - Movement Disorders for the General Neurologist III: Chorea, Dystonia, Myoclonus, Stereotypies, and Tics Shyamal Mehta MD, PhD
S53 - Movement Disorders: Genetics and Clinical Features
7:00 PM-10:00 PM
C240 - Case Studies: Unusual Movement Disorders Kailash Bhatia MD, FAAN

Friday, May 10, 2019
7:00 AM-9:00 AM
C246 - Hot Topics and Controversies in Parkinson's Disease Melissa Nirenberg MD, PhD, FAAN
1:00 PM-3:00 PM
C253 - Update in Movement Disorders Alfonso Fasano MD, PhD

Footer